| |
 |
|
Class Information
Number: 424/141.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology)
Description: Subject matter involving an antibody or fragment thereof produced by a clone of cells or cell line, which clone of cells or cell line is derived from a single antibody-producing cell or antibody-fragment-producing cell, wherein said antibody or fragment thereof is identical to all other antibodies or fragments thereof produced by that clone of cells or cell line.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/150.1 |
Binds bacterium or component thereof or substance produced by said bacterium |
227 |
| 424/146.1 |
Binds enzyme |
107 |
| 424/152.1 |
Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell |
343 |
| 424/145.1 |
Binds hormone or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., cytokine, etc.); or binds serum protein, plasma protein (e.g., tpa, etc.), or fibrin |
560 |
| 424/151.1 |
Binds parasitic organism (i.e., parasitic protozoan, multicellular ectoparasite (e.g., flea, tick, mite, etc.), or multicellular endoparasite (e.g., parasitic worm, etc.)) or component thereof or substance produced by said parasitic organism |
67 |
| 424/143.1 |
Binds receptor |
768 |
| 424/147.1 |
Binds virus or component thereof |
133 |
| 424/142.1 |
Human |
361 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7619068 |
Ovr110 antibody compositions and methods of use |
Nov. 17, 2009 |
| 7618633 |
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
Nov. 17, 2009 |
| 7618631 |
Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs |
Nov. 17, 2009 |
| 7618629 |
Manipulation of cytokine levels using CD83 gene products |
Nov. 17, 2009 |
| 7618625 |
Compositions comprising large and small binding fragments of antibodies against the same toxin |
Nov. 17, 2009 |
| 7615616 |
Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
Nov. 10, 2009 |
| 7615383 |
Methods for treating neuropathy by agonist anti-trk-C monoclonal antibodies |
Nov. 10, 2009 |
| 7615220 |
High affinity human antibodies to human IL-18 receptor |
Nov. 10, 2009 |
| 7615219 |
Inhibition of PACAP signalling for the prevention and treatment of thrombocytopenia |
Nov. 10, 2009 |
| 7615215 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7615214 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7611708 |
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
Nov. 3, 2009 |
| 7611707 |
Glycoprotein VI antibodies and methods thereof |
Nov. 3, 2009 |
| 7611706 |
RG1 antibodies and uses thereof |
Nov. 3, 2009 |
| 7611705 |
Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases |
Nov. 3, 2009 |
| 7611704 |
Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids |
Nov. 3, 2009 |
| 7608696 |
IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
Oct. 27, 2009 |
| 7608694 |
Antibody molecules having specificity for human IL-1.beta. |
Oct. 27, 2009 |
| 7608265 |
Treatment for bacterial infections |
Oct. 27, 2009 |
| 7608263 |
RG1 antibodies and uses thereof |
Oct. 27, 2009 |
| 7608262 |
Methods of preventing or treating thrombosis with tumor necrosis factor antagonists |
Oct. 27, 2009 |
| 7605238 |
Human CTLA-4 antibodies and their uses |
Oct. 20, 2009 |
| 7605233 |
Tumour necrosis factor binding ligands |
Oct. 20, 2009 |
| 7604800 |
Anti-PSGL-1 antibodies |
Oct. 20, 2009 |
| 7604799 |
EphA4 Antibodies |
Oct. 20, 2009 |
| 7601818 |
Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
Oct. 13, 2009 |
| 7601352 |
Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA |
Oct. 13, 2009 |
| 7601350 |
Antibodies that bind M. tuberculosis polypeptides |
Oct. 13, 2009 |
| 7597893 |
Human monoclonal antibody specific lipopolysaccharides (LPS) of serotype IATS 06 of Pseudomonas aeruginosa |
Oct. 6, 2009 |
| 7597891 |
Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases |
Oct. 6, 2009 |
| 7597888 |
Glycoprotein VI and uses thereof |
Oct. 6, 2009 |
| 7597886 |
Tumor necrosis factor-gamma |
Oct. 6, 2009 |
| 7595051 |
Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies |
Sep. 29, 2009 |
| 7595047 |
Compositions and methods for promoting or inhibiting angiogenesis |
Sep. 29, 2009 |
| 7595046 |
Treatment of cancer using anti-Apo-2 antibodies |
Sep. 29, 2009 |
| 7592007 |
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
Sep. 22, 2009 |
| 7592006 |
Composition comprising the LO-CD2a antibody |
Sep. 22, 2009 |
| 7592004 |
Stable lyophilized pharmaceutical formulation of IgG antibodies |
Sep. 22, 2009 |
| 7589182 |
Anti-sulfotyrosine antibodies |
Sep. 15, 2009 |
| 7589181 |
Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use |
Sep. 15, 2009 |
| 7588760 |
Antagonists specific for denatured collagen and methods of using same |
Sep. 15, 2009 |
| 7585953 |
Antibodies specific for TAT285-1 |
Sep. 8, 2009 |
| 7585502 |
Mammalian CX.sub.3C chemokine antibodies |
Sep. 8, 2009 |
| 7585501 |
Compositions and methods for treating kidney disease |
Sep. 8, 2009 |
| 7585500 |
Fully human monoclonal antibodies to IL-13 |
Sep. 8, 2009 |
| 7582299 |
Cripto-specific antibodies |
Sep. 1, 2009 |
| 7582297 |
Methods of treating respiratory conditions |
Sep. 1, 2009 |
| 7582296 |
Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof |
Sep. 1, 2009 |
| 7582294 |
Medicament for treating prostate diseases |
Sep. 1, 2009 |
| 7579448 |
Purification of microbial cell fermentation homogenates |
Aug. 25, 2009 |
|
|
|
